Unicycive Therapeutics, Inc.
UNCY
$5.12
$0.091.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 73.29% | -2,349.65% | 31.86% | -46.73% | -165.42% |
| Total Depreciation and Amortization | 9.42% | 56.30% | 12.69% | 20.33% | 222.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,705.58% | 171.47% | -34.97% | 70.67% | 101.22% |
| Change in Net Operating Assets | 61.01% | 144.27% | -221.03% | 105.74% | -2,237.04% |
| Cash from Operations | 9.69% | 29.90% | -22.66% | 35.56% | -33.25% |
| Capital Expenditure | 116.67% | 50.00% | 100.00% | 91.67% | 70.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -283.33% | -32,118.75% | -54,768.18% | 91.67% | 70.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 31.40% | 623.08% | 897.22% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -29.19% | -147.95% | 35.53% | -419.11% | -221.83% |
| Cash from Financing | 31.47% | 668.62% | 1,709.86% | 16,871.97% | 1,454.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.38% | 228.24% | -117.52% | 315.92% | 135.78% |